Our top pick for
Tivity Health, Inc is a medical care facilities business based in the US. Tivity Health shares (TVTY) are listed on the NASDAQ and all prices are listed in US Dollars. Tivity Health employs 1,000 staff and has a trailing 12-month revenue of around USD$1.1 billion.
|52-week range||USD$1.92 - USD$25.45|
|50-day moving average||USD$22.4391|
|200-day moving average||USD$17.8085|
|Wall St. target price||USD$21.38|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.424|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Tivity Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tivity Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tivity Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Tivity Health shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Tivity Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.662. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tivity Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Tivity Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$219 million.
The EBITDA is a measure of a Tivity Health's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.1 billion|
|Operating margin TTM||13.26%|
|Gross profit TTM||USD$453.1 million|
|Return on assets TTM||5.66%|
|Return on equity TTM||-195.42%|
|Market capitalisation||USD$1.2 billion|
TTM: trailing 12 months
There are currently 8.1 million Tivity Health shares held short by investors – that's known as Tivity Health's "short interest". This figure is 7.3% up from 7.5 million last month.
There are a few different ways that this level of interest in shorting Tivity Health shares can be evaluated.
Tivity Health's "short interest ratio" (SIR) is the quantity of Tivity Health shares currently shorted divided by the average quantity of Tivity Health shares traded daily (recently around 424789.22753547). Tivity Health's SIR currently stands at 19.03. In other words for every 100,000 Tivity Health shares traded daily on the market, roughly 19030 shares are currently held short.
However Tivity Health's short interest can also be evaluated against the total number of Tivity Health shares, or, against the total number of tradable Tivity Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tivity Health's short interest could be expressed as 0.17% of the outstanding shares (for every 100,000 Tivity Health shares in existence, roughly 170 shares are currently held short) or 0.2994% of the tradable shares (for every 100,000 tradable Tivity Health shares, roughly 299 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Tivity Health.
Find out more about how you can short Tivity Health stock.
We're not expecting Tivity Health to pay a dividend over the next 12 months.
Tivity Health's shares were split on a 2:1 basis on 22 December 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Tivity Health shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Tivity Health shares which in turn could have impacted Tivity Health's share price.
Over the last 12 months, Tivity Health's shares have ranged in value from as little as $1.92 up to $25.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tivity Health's is 2.4626. This would suggest that Tivity Health's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tivity Health, Inc. provides fitness, nutrition, and social connection solutions in the United States. It operates through two segments, Healthcare and Nutrition. The Healthcare segment offers SilverSneakers senior fitness program to the members of Medicare advantage and Medicare supplement programs; Prime fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The Nutrition segment provides weight management products and services under the Nutrisystem, South Beach Diet, and Wisely Well names. This segment sells pre-packaged foods comprising frozen and non-frozen, and shelf-stable products directly to weight loss program participants primarily through the Internet and telephone; QVC, a television shopping network; and retailers. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.